Skip to main content
Premium Trial:

Request an Annual Quote

Magellan Biosciences Acquires TekCel for Undisclosed Amount

NEW YORK, May 16 (GenomeWeb News) - Magellan Biosciences, based in Chelmsford, Mass., has acquired Hopkinton, Mass.-based TekCel for an undisclosed amount, the company said today.

 

Magellan provides instruments and consumables for biomedical research and clinical diagnostics. TekCel provides automated sample management and assay automation systems.

 

According to Magellan, TekCell employs approximately 35 people, all of whom are expected to remain with the company.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.